Evidence map›Paper›PMID 40795828›Full record

ArticleBioinformatics (Oxford, England)2025

Sequence-only prediction of binding affinity changes: a robust and interpretable model for antibody engineering.

Chen Liu, Mingchen Li, Yang Tan, Wenrui Gou, Guisheng Fan, Bingxin Zhou

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chen LiuSchool of Information Science and Engineering, East China University of Science and Technology, Shanghai 200237, China.ORCID 0009-0007-5210-1769
Mingchen LiSchool of Information Science and Engineering, East China University of Science and Technology, Shanghai 200237, China.
Yang TanSchool of Information Science and Engineering, East China University of Science and Technology, Shanghai 200237, China.ORCID 0009-0004-7261-1705
Wenrui GouSchool of Information Science and Engineering, East China University of Science and Technology, Shanghai 200237, China.
Guisheng FanSchool of Information Science and Engineering, East China University of Science and Technology, Shanghai 200237, China.
Bingxin ZhouInstitute of Natural Sciences, Shanghai Jiao Tong University, Shanghai 200240, China.ORCID 0000-0002-3897-9766

Funding

National Science Foundation of China 62302291
6 · The paper itself

Abstract

motivationA pivotal area of research in antibody engineering is to find effective modifications that enhance antibody-antigen binding affinity. Traditional wet-lab experiments assess mutants in a costly and time-consuming manner. Emerging deep learning solutions offer an alternative by modeling antibody structures to predict binding affinity changes. However, they heavily depend on high-quality complex structures, which are frequently unavailable in practice. Therefore, we propose ProtAttBA, a deep learning model that predicts binding affinity changes based solely on the sequence information of antibody-antigen complexes.

resultsProtAttBA employs a pre-training phase to learn protein sequence patterns, following a supervised training phase using labeled antibody-antigen complex data to train a cross-attention-based regressor for predicting binding affinity changes. We evaluated ProtAttBA on three open benchmarks under different conditions. Compared to both sequence- and structure-based prediction methods, our approach achieves competitive performance, demonstrating notable robustness, especially with uncertain complex structures. Notably, our method possesses interpretability from the attention mechanism. We show that the learned attention scores can identify critical residues with impacts on binding affinity. This work introduces a rapid and cost-effective computational tool for antibody engineering, with the potential to accelerate the development of novel therapeutic antibodies. AVAILABILITY AND IMPLEMENTATION: Source codes and data are available at https://github.com/code4luck/ProtAttBA.

Indexed as

AntibodiesAntibody AffinityDeep LearningProtein EngineeringAntigen-Antibody ComplexProtein BindingAntibodiesAntigen-Antibody Complex

Identifiers

PMID40795828
PMCPMC12371331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.